Similar articles

• Propranolol in black hypertensives.

  Grell GA. Grell GA. Br Med J. 1978 Jul 29;2(6133):358. doi: 10.1136/bmj.2.6133.358-b. Br Med J. 1978. PMID: 687925 Free PMC article. No abstract available.
• Ineffectiveness of propranolol in hypertensive Jamaicans.

  Humphreys GS, Delvin DG. Humphreys GS, et al. Br Med J. 1968 Jun 8;2(5605):601-3. doi: 10.1136/bmj.2.5605.601. Br Med J. 1968. PMID: 4871610 Free PMC article. Clinical Trial. No abstract available.
• Comparison of nifedipine and propranolol as second line agent for hypertension in black Kenyans.

  Poulter NR, Sanderson JE, Thompson AV, Sever PS, Chang CL. Poulter NR, et al. BMJ. 1993 Mar 6;306(6878):621-2. doi: 10.1136/bmj.306.6878.621. BMJ. 1993. PMID: 8461812 Free PMC article. Clinical Trial. No abstract available.
• Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.

  Oster G, Huse DM, Delea TE, Savage DD, Colditz GA. Oster G, et al. J Natl Med Assoc. 1987 Oct;79(10):1049-55. J Natl Med Assoc. 1987. PMID: 3119865 Free PMC article. Review.
• Racial difference in response to antihypertensive drugs. A focus on verapamil.

  Cubeddu LX. Cubeddu LX. J Clin Hypertens. 1986 Sep;2(3 Suppl):72S-78S. J Clin Hypertens. 1986. PMID: 3540228 Review. No abstract available.